Webcast

/Webcast

LRG Webcast Series: Updates on the Temozolomide Trial

Dr. Jason Sicklick of Moores Cancer Center at the University of California San Diego talks about the Phase II study of Temozolomide (TMZ) in advanced SDH-mutant/deficient GIST, a new study available to patients with SDH-deficient GIST.

By |2019-09-16T16:29:29-04:00September 16th, 2019|Clinical Trials, News, Webcast|

LRG Webcast Series: When to Consider Surgery

Most GIST patients will see a surgeon at some point during their treatment. This webcast will address the issues surrounding the decision to have an operation and considers that surgical options depend on a number of factors such as tumor location, tumor size, tumor number, response to drug therapy, and risk of recurrence.

By |2019-09-16T13:13:09-04:00August 14th, 2019|News, Surgery, Webcast|

LRG Webcast Series: Novel Therapies in GIST

SPAEN (Sarcoma Patients EuroNet) Presents Webinar Webinar "Novel therapy options in GIST: What's on the horizon?" was presented by Dr. Jonathan Trent, Professor of Medicine, Associate Director, Clinical Research Director, Sarcoma Medical Research Program [...]

By |2019-08-14T13:36:30-04:00July 31st, 2019|GIST Education, SDH-Deficient GIST, Webcast|

LRG Webcast: GIST – El punto de vista del patólogo

Presentación del Dr. Chris Corless, profesor de patología en la Universidad de Oregón. Habla desde experiencia como patólogo trabajando con los tumores del estroma gastrointestinal (GIST). Nos actualiza sobre diagnóstico, mutaciones, riesgos de recurrencia, [...]

By |2019-07-09T11:08:58-04:00July 8th, 2019|Global, News, Webcast|